<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"adipophilin":1,
"apocrine-like features":1,
"lipogenic pathway":1,
"lung adenocarcinoma":4,
"prognosis":25,
"Epigenetics":3,
"Medullary thyroid carcinoma":11,
"MicroRNA":6,
"Noncoding RNA":1,
"RET":5,
"central neck dissection":1,
"occult lymph node metastasis":1,
"papillary thyroid carcinoma":56,
"prophylactic neck dissection":1,
"Anaplastic thyroid carcinoma":5,
"Non-coding RNA":1,
"Poorly differentiated thyroid carcinoma":3,
"Cabeça e pescoço":1,
"Free flaps":1,
"Head and neck":4,
"Outcomes":1,
"Reconstruction":2,
"Reconstrução":1,
"Resultados":1,
"Retalhos livres":1,
"Epigenetic drugs":1,
"Epigenetic writers":1,
"Histone deacetylase and acetyl transferase":1,
"Thyroid cancer cells":1,
"erasers and readers":1,
"Antitiroglobulina elevada":1,
"Chronic lymphocytic thyroiditis":1,
"Câncer de tireoide":1,
"Doença persistente e recorrente":1,
"Elevated antithyroglobulin":1,
"Persistent and recurrent disease":1,
"Thyroid cancer":77,
"Tireoidite linfocítica crônica":1,
"Biomarkers":6,
"Follicular thyroid carcinoma":4,
"Thyroid tumors":1,
"Diagnosis":11,
"LncRNAs":2,
"Metabolic syndrome":2,
"Prevalence":1,
"Ultrasonography":20,
"Thyroid nodule":27,
"Isthmusectomy":1,
"Thyroid isthmus":1,
"Total thyroidectomy":1,
"Iodine":3,
"Iodolipid":1,
"ROS":3,
"Thyroid":35,
"Anaplastic thyroid cancer":4,
"Benign thyroid disease":2,
"Familial non-medullary thyroid cancer":1,
"Papillary thyroid cancer":20,
"Penetrance":1,
"Risk":3,
"NOX4":1,
"Selenium":1,
"TGF-β":1,
"Biopsy, fine-needle":1,
"Biopsy, large-core needle":1,
"Thyroid neoplasms":17,
"Differentiated thyroid cancer":10,
"Efficacy":2,
"Meta-analysis":9,
"Pulmonary metastasis":1,
"Radioiodine therapy":4,
"BRAF":5,
"MassARRAY":1,
"NTRK1":1,
"TERT":3,
"Aspirin":1,
"Circulating tumor cells":1,
"Epithelial–mesenchymal transformation":1,
"Vimentin":1,
"Endoscopic":1,
"Thyroid surgery":6,
"Transoral":3,
"adequacy":1,
"fine-needle aspiration biopsy":3,
"thyroid/parathyroid":2,
"3-dimensional":1,
"elastography":5,
"shear wave elastography":2,
"ultrasound":15,
"Adrenal insufficiency":2,
"Autoimmune hypophysitis":1,
"Immune checkpoint inhibitors":2,
"Immune related adverse events":1,
"Thyroiditis":2,
"cytology":7,
"diagnostic accuracy":2,
"HGF/Met":1,
"TR4":1,
"metastasis":12,
"nuclear receptor":1,
"renal cell carcinoma":2,
"TI-RADS":4,
"biopsy":4,
"quality assurance":1,
"standardization":2,
"thyroid nodules":13,
"EGFR inhibitors":1,
"Rash":1,
"Rash management":1,
"Treatment costs":1,
"Treatment persistence":1,
"Radioactive remnant ablation":1,
"TSH stimulation":1,
"Big data":1,
"Cancer management":1,
"Data pooling":1,
"Personalized medicine":2,
"Radiotherapy":7,
"European reference networks joint action of rare cancers":1,
"Head and neck cancer":3,
"Multidisciplinary team":1,
"Rare disease":1,
"eosinophilia":1,
"fine-needle aspiration":11,
"sclerosing mucoepidermoid carcinoma":1,
"Aggregation assays":1,
"CGRP family":1,
"Type 2 diabetes":1,
"αCGRP":1,
"‘Aggregation-prone’ peptide":1,
"aggressive variant":1,
"solid":1,
"solid variant":1,
"solid/trabecular":1,
"trabecular":1,
"incidental thyroid nodules":1,
"thyroid incidentalomas":2,
"OCT4":1,
"SOX2":1,
"Triple-negative breast cancer":2,
"Tumor tissue":1,
"consumptive hypothyroidism":2,
"Hemangioma":1,
"type 3 iodothyronine deiodinase, propranolol":1,
"Chemical oxygen demand":1,
"Geographically weighted regression":1,
"Industrial density":1,
"Spatial scan statistics":1,
"ATC":3,
"PTCSC3":1,
"STAT3":3,
"doxorubicin":4,
"drug resistance":1,
"Multiple correspondence analysis":1,
"Prospective observational trial":1,
"DPP-4 inhibitors":1,
"site-specific cancer":1,
"systematic literature review":1,
"cell proliferation and cytokinesis":1,
"filament formation":1,
"nervous and reproductive systems":1,
"septin7":1,
"epidemiology":4,
"incidence":6,
"pediatric head and neck cancer":1,
"Desmoplastic reaction":1,
"Fibrosis":1,
"Myofibroblast":1,
"Pancreatic ductal adenocarcinoma":1,
"carcinosarcoma":2,
"pilomatricoma":1,
"pilomatrix carcinoma":1,
"pilomatrix carcinosarcoma":1,
"sarcomatoid pilomatrix carcinoma":1,
"CNS tumors":1,
"neuro-oncology":1,
"pediatric hematology/oncology":1,
"radiation oncology":1,
"radiation therapy":1,
"ALK":1,
"Chernobyl":2,
"ionising radiation":2,
"Afirma gene expression classifier (GEC)":1,
"ThyroSeq":2,
"molecular":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":3,
"Frozen autograft":1,
"Recapping laminoplasty":1,
"Tenosynovial giant cell tumor":1,
"Thoracic spine":1,
"fucose":1,
"glycosylation":1,
"lectin":1,
"sialic acid":1,
"thyroid carcinoma":11,
"ATA risk stratification":1,
"disease-free survival":2,
"dynamic risk stratification":2,
"proportion of variance explained":1,
"structural recurrence":1,
"thyroid lobectomy":3,
"Cell senescence":1,
"NF-κB":2,
"Punicalagin":1,
"Senescence-associated secretory phenotype (SASP)":1,
"Carcinoma extension":1,
"Lymph node metastasis":8,
"Papillary carcinoma":5,
"Tumor-node-metastasis staging system":2,
"cancer":15,
"circadian rhythm disruption":1,
"cohort studies":2,
"cosmic ionizing radiation":1,
"exposure response":1,
"flight attendants":1,
"Bilateral breast approach":1,
"Operating bed adjustment":1,
"Skin traction point":1,
"Standardization of simple auxiliary method":1,
"Thyroid retractor point":1,
"Total endoscopic thyroidectomy":1,
"copy number gain":1,
"follicular thyroid tumour":1,
"hypermethylation":2,
"mutation":3,
"Cyclic fluctuation of serum TSH levels":1,
"TSH-secreting pituitary adenoma":1,
"interobserver agreement":1,
"interobserver variability":1,
"thyroid malignancy":4,
"thyroid ultrasound":3,
"Chinese population":1,
"POLR2E":1,
"rs3787016":1,
"Radioiodine":4,
"CyclinD1":1,
"Gefitinib":1,
"PKM2":2,
"Shikonin":1,
"Thyroid gland":7,
"adolescents and young adults (AYAs)":1,
"cancer survivors":1,
"conditional survival":1,
"relative survival":2,
"dabrafenib":3,
"pembrolizumab":1,
"sarcomatoid":1,
"squamous":1,
"trametinib":4,
"undifferentiated":2,
"aspiration":1,
"capillary action":1,
"needle gauge":1,
"non-diagnostic rate":1,
"thyroid fine-needle biopsy":1,
"ablation":1,
"extrathyroidal extension":3,
"low-dose":1,
"lymph node metastases":1,
"radioactive iodine":2,
"(18)F-DOPA":1,
"Carcinoma medular de tiroides":1,
"Cirugía radioguiada":1,
"Metastasectomy":1,
"Metastasectomía":1,
"Radioguided surgery":1,
"Power Doppler ultrasound":1,
"contrast-enhancement ultrasound":1,
"quantitative imaging":1,
"tumor vascularity":1,
"I-131 remmnant ablation":1,
"Low dose of I-131":1,
"Low-iodine diet":1,
"Urinary iodine":1,
"complications":2,
"lingual thyroid":1,
"miscellaneous":1,
"surgical outcomes":1,
"VWD":1,
"VWF":1,
"diabetes":2,
"elderly":1,
"Adipose tissue":1,
"Breast cancer":20,
"Monocarboxylate transporters":1,
"incidental cancer":1,
"incidental detection":1,
"overdiagnosis":3,
"thyroid cancer incidence":1,
"Central lymph node metastasis":1,
"Microcarcinoma":3,
"Nomogram":1,
"metformin":1,
"population-based study":1,
"protective effect":1,
"TSH receptor":1,
"inverse agonist":1,
"monoclonal antibody":1,
"bone marrow dosimetry":1,
"remnant tissue dosimetry":1,
"thyroid ablation treatment":1,
"lymphocytic thyroiditis":1,
"radioiodine ablation":1,
"thyroglobulin":7,
"thyroglobulin antibodies":1,
"Brain metastasis":1,
"Skull metastasis":2,
"Surgery":7,
"Viscum album":1,
"mistletoe":1,
"rectal cancer":1,
"Microvascular free flap":1,
"Oral cancer":1,
"Squamous cell carcinoma":4,
"UW-QoL v4":1,
"oral reconstruction":1,
"Liquid-based cytology":1,
"Hyalinizing trabecular tumor":1,
"focal adhesion kinase/extracellular signal-regulated kinase":1,
"human epidermal growth factor receptor 2":1,
"microRNA-150":1,
"mucin 4":1,
"copy-number variation":1,
"genome-wide linkage analysis":1,
"multinodular goiter":2,
"next-generation sequencing":2,
"SEER database":1,
"Salivary gland malignancy":1,
"Second primary malignancy":1,
"X-Ray":1,
"Computed Tomography":3,
"Frontal Sinus":1,
"Inverted Papilloma":1,
"Magnetic Resonance Imaging":1,
"Paranasal Sinus Diseases":1,
"Angiosarcoma":1,
"Chemotherapy":4,
"Sarcoma":2,
"Therapy":2,
"Treatment":3,
"Cbp/p300-interacting transactivator with glutamic acid and aspartic acid rich C-terminal domain 1":1,
"gene":1,
"anticancer perspectives":1,
"hydroxytyrosol":1,
"metabolism":5,
"oleuropein":1,
"olive oil phenols":1,
"Molecular pathology":1,
"Oncogene addiction":1,
"Somatic mutation":1,
"Thyroid tumor":1,
"infantile hepatic haemangioma":1,
"type 3 iodothyronine deiodinase":1,
"distant metastasis":1,
"pediatric thyroid cancer":1,
"pre-ablation stimulated thyroglobulin":1,
"Fluorodeoxyglucose":2,
"positron emission tomography-computed tomography":1,
"radioiodine scan":1,
"thyroglobulin nonsecretor":1,
"68Ga-DOTANOC":1,
"68Ga-prostate-specific membrane antigen":1,
"positron emission tomography/computed tomography":1,
"Guideline":3,
"Recommendation":1,
"RF ablation":1,
"Radiofrequency ablation":3,
"Thyroid recurrent cancers":1,
"Biopsy technique":1,
"Core needle biopsy (CNB)":1,
"Fine-needle aspiration (FNA)":1,
"Follicular-patterned lesion":1,
"Artificial intelligence":1,
"Computer-aided diagnosis":1,
"Echogenicity":1,
"Histopathology":1,
"Large-core needle":1,
"Computer-aided unsupervised clustering method":1,
"Gastric cancer":2,
"Tumor-node-metastasis staging":1,
"Molecular testing":3,
"Pathology":6,
"Pleomorphism":1,
"Gonadal hormone":1,
"Obesity":2,
"Radioactive iodide therapy":1,
"Sodium iodide symporter":1,
"Thyroid hormone":1,
"Thyroid hormone receptor":2,
"carcinoma, papillary":1,
"cysts":1,
"neck":1,
"thyroglossal cyst":1,
"endoscopy":3,
"mental nerve":1,
"thyroidectomy":15,
"131I thyroid dose":1,
"age-matched groups":1,
"radiation":2,
"atherosclerosis":1,
"coronary artery bypass grafting":1,
"low-density lipoprotein cholesterol":1,
"proprotein convertase subtilisin/kexin type 9 (pcsk9)":1,
"saphenous vein grafts disease":1,
"Carcinoid tumor":1,
"Immunohistochemistry":12,
"Ovarian neoplasms":1,
"Thyroid diseases":2,
"Immunotherapy":5,
"Lenvatinib":4,
"Salvage":1,
"Encapsulated follicular variant of papillary thyroid carcinoma":1,
"indolent behavior":1,
"noninvasive follicular thyroid tumor with papillary-like nuclear features":1,
"revised nomenclature":1,
"Autotransplanted thyroid":1,
"thyroid metastasis":1,
"thyroid neoplasm":3,
"digital pathology":1,
"tall-cell variant":1,
"AKT":2,
"Activation":1,
"Expression":1,
"Isoform":1,
"Phosphorylation":1,
"RPPA":1,
"Anti-programmed cell death-1":1,
"Hepatocellular carcinoma":2,
"Immune-related adverse event":1,
"Sick sinus syndrome":1,
"Central diabetes insipidus":1,
"Cerebral salt wasting syndrome":1,
"Hyponatremia":1,
"Pituitary":1,
"MEK (mitogen-activated protein kinase kinase) inhibitor":1,
"miRNAs":1,
"radioiodine refractory differentiated thyroid cancer":1,
"Denmark":1,
"incidental findings":1,
"iodine deficiency":1,
"neoplasms":4,
"positron emission tomography":2,
"Anaplastic thyroid cancer (ATC)":1,
"Apoptosis":5,
"Green fluorescent protein (GFP)":1,
"Newcastle disease virus (NDV)":1,
"p38 MAPK":1,
"unknown primary tumor":1,
"Industry":1,
"Women, Working":1,
"multidrug resistance":1,
"nanostructured lipid carriers":1,
"β-lapachone":1,
"I-131":1,
"fluid":1,
"whole body retention":1,
"N-nitroso compounds":1,
"adverse reproductive outcomes":1,
"drinking water":1,
"endogenous nitrosation":1,
"methemoglobinemia":1,
"nitrate":1,
"thyroid disease":6,
"Breast reconstruction":1,
"Core needle biopsy":3,
"Oncoplastic breast surgery":1,
"Phyllodes tumor":1,
"NASH":1,
"T2":1,
"T3":1,
"liver cell proliferation":1,
"regenerative medicine":1,
"thyromimetics":1,
"SPINA-GT":1,
"TSH index":1,
"calcification":1,
"coronary artery calcification":1,
"thyroid hormones":3,
"carcinoma":4,
"fine needle aspiration (FNA)":1,
"indeterminate":1,
"nodule":1,
"Age":3,
"Disparity":1,
"adrenal disorders":1,
"metabolic disorders":1,
"Malignant struma ovarii":1,
"Oopherectomy":1,
"Salipingo-oopherectomy":1,
"Total abdominal hysterectomy":1,
"Carcinogenesis":1,
"DNA methylation":1,
"Epigenomics":1,
"Infection":1,
"L56M":1,
"MEN2":2,
"pheochromocytoma":3,
"Asymptomatic":1,
"Hashimoto's thyroiditis":3,
"female preponderance":1,
"subclinical hypothyroid":1,
"Biphasic tumor":1,
"DICER1 mutation":1,
"Lung metastasis":1,
"RET mutation":1,
"calcitonin":4,
"multiple endocrine neoplasia type 2":1,
"PTC, RAS":1,
"point mutation":1,
"struma ovarii":1,
"cerebriform nuclei":1,
"colloid inclusion":1,
"marginal vacuoles":1,
"nuclear grooves":1,
"Coexistence":1,
"primary thyroid lymphoma":2,
"Anesthesia":1,
"lung mass":1,
"mucoepidermoid":1,
"Cell proliferation":2,
"SOS1":1,
"microRNA-4728 (miR-4728)":1,
"HIF inhibitors":1,
"Metastatic Pheochromocytoma":1,
"Metastatic paraganglioma":2,
"tyrosine kinase inhibitors":3,
"NGAL":1,
"chemokines":1,
"chemotaxis":1,
"Diffuse B-cell lymphoma":1,
"BRAF V600E":4,
"RAS mutations":2,
"Esophageal carcinoma":1,
"small cell carcinoma":1,
"CT":1,
"Dose reduction":1,
"Cytokeratin7":1,
"breastadenocarcinoma":1,
"cervicalcancer":1,
"F-18 fluorodeoxyglucose":1,
"incidentaloma":1,
"maximum standardized uptake value":1,
"positron emission tomography computed tomography":1,
"Carcinoma thyroid":1,
"poorly differentiated":1,
"RNA editing":1,
"alternative splicing":1,
"circular RNAs":1,
"drug susceptibility":1,
"long non-coding RNAs":1,
"hyperthyroidism":6,
"Differentiation markers":1,
"Sensitivity and Specificity":1,
"Transcription factors":1,
"Tumor markers":1,
"Adrenocortical carcinoma":2,
"liver":1,
"(100 2960) Image analysis":1,
"(170 6935) Tissue characterization":1,
"(180 4315) Nonlinear microscopy":1,
"Strain Elastography":1,
"minimally invasive surgery":1,
"robot-assisted transaxillary thyroidectomy":1,
"CTCs":1,
"Endocrine system diseases":1,
"cfDNA":1,
"ER-stress":1,
"TrxR1":1,
"alantolactone":1,
"gastric metastasis":1,
"FOXD2-AS1":1,
"Therapeutic target":1,
"lncRNA":3,
"neuroimaging":1,
"pituitary disorders":1,
"Fluorescence in-situ hybridization":1,
"Hürthle cell":2,
"CTLA-4":1,
"PD-1":2,
"PD-L1":1,
"hypophysitis":3,
"thyroid disorders":3,
"fluorodeoxyglucose F18":1,
"lymph node":2,
"cervical metastases":1,
"chronic diarrhea":1,
"metastatic medullary thyroid carcinoma":1,
"Crohn’s disease":2,
"Korea":1,
"Ulcerative colitis":2,
"population-based":2,
"Endocrine surgery":2,
"general surgery":1,
"multidisciplinary":1,
"online referrals":1,
"otolaryngology":1,
"self-referred":1,
"Calcificaciones":1,
"Calcifications":1,
"Carcinoma tiroideo":1,
"Doppler":2,
"Ecografía":1,
"Elastografía":1,
"Malignancy":4,
"Malignidad":1,
"Nódulo tiroideo":2,
"fine needle aspiration":3,
"De novo cancer":1,
"Head and neck malignancy":1,
"Immunosuppression":1,
"Organ recipients":1,
"Organ transplantation":1,
"Solid organ transplantation":1,
"Risk factors":5,
"Thyroid thyroglobulin antibody":1,
"Thyroid-stimulating hormone":2,
"agreement":1,
"ETV6":1,
"fluorescent in situ hybridization":1,
"mammary analogue secretory carcinoma":1,
"Anti-tumor":1,
"Head and neck squamous cell carcinoma":1,
"SPOCK1":1,
"miR-150-3p":1,
"miR-150-5p":1,
"anti-glutamate receptor antibody":1,
"limbic encephalitis":1,
"paraneoplastic syndrome":1,
"thymoma":1,
"Microwave ablation":3,
"Checkpoint inhibitors":1,
"Immunostimulation":1,
"Monoclonal antibodies":1,
"PD-1 blockade":1,
"Side effects":1,
"Expanding indications":1,
"Robotic thyroidectomy":1,
"Surgical completeness":1,
"Surgical safety":1,
"nodule volume":1,
"thyroid function":2,
"Benign thyroid nodule":2,
"stress":1,
"Percutaneous laser ablation":1,
"toxic nodules":1,
"Lung squamous cell carcinoma":1,
"TTF-1":4,
"p40":1,
"guidelines":1,
"Cortisol":1,
"Fatigue":1,
"Levothyroxine":2,
"high-intensity focused ultrasound (HIFU)":1,
"thermal ablation":2,
"Diagnostic":2,
"Hypophysite":1,
"Immunothérapie":1,
"Traitement":1,
"Benign metastasizing leiomyoma":1,
"Driver gene":1,
"Targeted deep sequencing":1,
"Uterine leiomyoma":1,
"pesticides":1,
"review":1,
"Pediatric thyroid cancer survivors":1,
"SEER":3,
"Second malignancy":1,
"Crete":1,
"Gamma-ray":1,
"fine-needle aspiration cytology":2,
"mixed medullary-follicular carcinoma":1,
"adolescents":2,
"young adults":2,
"classification":1,
"defect":1,
"palatomaxillary":1,
"prosthodontic":1,
"Ablation techniques":1,
"High-intensity focused ultrasound ablation":1,
"Interventional ultrasonography":1,
"Nodular goitre":1,
"Ultrasound imaging":1,
"melanoma":4,
"population surveillance":1,
"circulating tumor DNA":1,
"digital polymerase chain reaction (PCR)":1,
"papillary thyroid carcinoma (PTC)":3,
"IVLBCL":1,
"diagnostic pitfall":1,
"intravascular large B-cell lymphoma":2,
"thyroid lymphoma":1,
"BRAF mutation":3,
"The Cancer Genome Atlas (TCGA)":1,
"molecular subtypes":1,
"prediction":2,
"HER2":1,
"Ki-67":2,
"MIB-1":1,
"Membranous staining":1,
"IDH2":1,
"sanger sequencing":1,
"CO2 insufflation":2,
"cosmetic effect":1,
"suspension system":1,
"transoral endoscopic thyroid surgery":1,
"tri-vestibular approach":1,
"fine-needle aspiration (FNA) biopsy":1,
"imaging features":1,
"well differentiated thyroid carcinoma":1,
"molecular marker tests":1,
"Papillary thyroid microcarcinoma":3,
"microwaves":1,
"radioactive iodine therapy":3,
"adolescence":1,
"childhood":1,
"recurrence":4,
"Microcalcification":1,
"localization":1,
"radioactive":1,
"seed":1,
"Atovaquone":1,
"Mitochondrial respiration":1,
"craniospinal irradiation":1,
"medulloblastoma":1,
"photon radiation":1,
"second neoplasms":1,
"cabozantinib":1,
"pediatrics":1,
"phase 1":1,
"common 2D endoscopic technique":1,
"three-dimensional endoscopic technique":1,
"Chlordane":1,
"DDT":1,
"Organochlorines":1,
"Polychlorinated biphenyls":1,
"children":2,
"malignancies":1,
"Exosomes":2,
"Osteoclastogenesis":1,
"Pdcd4":1,
"miR-21":1,
"Thyroid Imaging, Reporting, and Data System (TI-RADS)":1,
"subcentimeter thyroid nodules":1,
"kinase inhibitors":2,
"oncogene":1,
"differentiated thyroid carcinoma":3,
"LRRC8D mutation":1,
"NDRG1 mutation":1,
"The Cancer Genome Atlas":1,
"Whole-exome sequencing":1,
"OSNA":1,
"Sensitivity":1,
"Specificity":1,
"Benign thyroid disorders":1,
"Population model":1,
"Radioiodine uptake":1,
"Variability":1,
"Mixed follicular-papillary variant":1,
"Multifocality":2,
"Thyroid weight":1,
"Tumour size":1,
"Pyruvate kinase M2":1,
"Afirma":1,
"Afirma test":1,
"Bethesda III":1,
"Bethesda IV":1,
"Citología indeterminada":1,
"Diagnóstico molecular":1,
"Indeterminate cytology":2,
"Molecular diagnosis":1,
"Thyroseq test":1,
"AZD2014":1,
"Chemo-resistance":1,
"Paclitaxel":1,
"Targeted therapy":3,
"mTOR":3,
"Endoscopic thyroidectomy":1,
"anterior neck surgery":1,
"breast approach":1,
"cosmesis":1,
"elastic traction":1,
"Cell cycle":3,
"Estrogen receptor":1,
"Long non-coding RNA":2,
"MIAT":1,
"Proliferation":9,
"FOXO1":1,
"GAS5":1,
"Progression":4,
"TNBC":1,
"miR-196a-5p":1,
"Follicular thyroid tumors":1,
"Chemoresistance":1,
"Glucose":1,
"Microenvironment":1,
"NEMO gene":1,
"X-linked recessive Mendelian susceptibility to mycobacterial diseases":1,
"nuclear factor-κB":1,
"Neoplasm":1,
"Shear wave":1,
"Clinical competence":1,
"Risk assessment":1,
"Dual-luciferase reporter gene assay":1,
"Insulin like growth factor 1 receptor":1,
"Invasion":9,
"Long noncoding RNA PVT1":1,
"Migration":4,
"RNA-pull down":1,
"ceRNA":1,
"microRNA-30a":1,
"EORTC QLQ-C30":1,
"SF-36":1,
"health-related quality of life":1,
"life style behavior":1,
"thyroid cancer survivors":1,
"lobectomy":3,
"low risk":1,
"thyroid cytology":1,
"TNM staging":1,
"follicular thyroid cancer":3,
"survival":7,
"Period and population analysis":1,
"Trends in thyroid cancer":1,
"TSH":1,
"Colon cancer":3,
"Dioscorea bulbifera":1,
"ERK1/2 and JNK":1,
"Antioxidant":1,
"Radiation mitigators":1,
"Radioiodine treatment":1,
"Radioprotector":1,
"Vitamin C":1,
"Intra-operative neural monitoring":1,
"Lymphadenectomy":1,
"Mesoesophagus":1,
"Prone esophagectomy":1,
"Recurrent laryngeal nerve":4,
"2D-DIGE":1,
"Honokiol":1,
"MALDI-TOF":1,
"Proteomics":3,
"radiomics":1,
"pediatric renal tumor":1,
"transcription factor E3 (TFE3) gene":1,
"transcription factor EB (TFEB) gene":1,
"translocation renal cell carcinoma":1,
"Robotic transaxillary approach":1,
"Robotic transaxillary surgery":1,
"Surgical treatment of thyroid cancer":1,
"Thyroid cancer outcomes":1,
"Well-differentiated thyroid cancer":1,
"autophagy":4,
"flavokawain B":1,
"Atypia":1,
"Fluoro-deoxy-glucose uptake (FDG uptake)":1,
"Follicular neoplasm":1,
"Positron emission tomography/computed tomography (PET/CT)":1,
"FSH":1,
"inhibin B":1,
"sperm aneuploidy":1,
"testicular function":1,
"Histogenesis":1,
"Thyroid squamous cell carcinoma":1,
"Central lymph node dissection":1,
"Permanent hypoparathyroidism":1,
"Recurrent laryngeal nerve injury":1,
"Reoperative central lymph node dissection":1,
"Thyroid cancer recurrence":1,
"tumor size":1,
"LINC00704":1,
"biomarker":4,
"profiling":1,
"chemotherapy-only conditioning":1,
"hematopoietic stem cell transplantation":1,
"pediatric recipients":1,
"Cancer methylation":1,
"Global DNA methylation":1,
"Glutaminase":1,
"Glutamine":1,
"Glutaminolysis":1,
"CD56":1,
"PCR":1,
"SLP-2":1,
"TROP-2":2,
"TCGA data":1,
"early cancer":1,
"gene expression":1,
"pattern recognition":1,
"screening method":1,
"signature genes":1,
"Case–control study":1,
"Odd ratio":1,
"Akt/GSK3β/β-catenin signaling pathway":1,
"IQ motif and ubiquitin domain containing":1,
"cell migration":1,
"adenocarcinoma":2,
"cell nucleus":1,
"follicular":1,
"histology":2,
"papillary":1,
"SLC5A5":1,
"positron emission tomograph":1,
"Li-Fraumeni syndrome":1,
"MEN1":1,
"endocrine tumour syndromes":1,
"genetics":2,
"Mouse models":1,
"Oncogenes":1,
"Oncology":4,
"P53":1,
"osteosarcoma":1,
"period analysis":1,
"sex":1,
"socioeconomic status":1,
"B-cell receptors":1,
"T-cell receptors":1,
"complementarity-determining region 3":1,
"high-throughput sequencing":1,
"Colorectal carcinoma":1,
"VE1":1,
"Contrast-enhanced ultrasound":1,
"Time-intensity curve":1,
"131-iodine whole-body scan":1,
"Nephrectomy":1,
"Renal tumour":1,
"Thyroid ectopia":1,
"BRAF-activated long noncoding RNA":1,
"cyclin D1":1,
"long noncoding RNA":2,
"thyroid stimulating hormone receptor":1,
"HOX transcript antisense intergenic RNA":1,
"Knowledge Explorer":1,
"Reactome":1,
"SPARQL reasoning":1,
"mass spectrometry":2,
"pathway analysis":1,
"random positioning machine":1,
"semantic network":1,
"Cone-beam computed tomography (CBCT)":1,
"Monte Carlo simulation":1,
"Organ doses":1,
"PCXMC":1,
"Risk of exposure-induced death (REID)":1,
"Child":1,
"Follow-up studies":1,
"EudraVigilance":1,
"Lithium":1,
"Renal cancer":1,
"VigiAccess":1,
"Fallopian tubal cancer":1,
"Ovarian cancer":1,
"Primary peritoneal cancer":1,
"Second primary":1,
"FTC":1,
"Molecular markers":2,
"NGS":1,
"PTC":4,
"Thyroxine":1,
"Triiodothyronine":1,
"endocrine cancer":2,
"urological cancer":1,
"GO–HAp":1,
"HSV-TK":1,
"gene therapy":1,
"nanoparticles":1,
"Imatinib mesylate":1,
"Rectal GIST":1,
"TAMIS":1,
"Hospital volume":1,
"Neck dissection":4,
"Overall survival":3,
"Recombinant human thyrotropin":1,
"Therapeutic response":1,
"18F":1,
"18F-NaF":1,
"68Ga":1,
"Gallium-68":1,
"PET/CT":2,
"carcinogens":1,
"eating habits":1,
"environment":1,
"iodine intake":1,
"volcanoes":1,
"xenobiotics":1,
"chromosomal losses":1,
"complex I":1,
"haploid":1,
"loss of heterozygosity":1,
"mitochondria":1,
"mtDNA":1,
"oncocytic":1,
"Hurthle cell carcinoma":2,
"copy-number alterations":1,
"fusion genes":1,
"genomics":2,
"mitochondrial mutations":1,
"transcriptome":1,
"Medullary":1,
"Multiple endocrine neoplasia":1,
"Pituitary adenoma":3,
"Pituitary neoplasms":1,
"Adrenocortical adenoma":1,
"Case Report":1,
"Hereditary Tumor Syndrome":1,
"Malignant Peritoneal Mesothelioma":1,
"PTEN-Hamartoma-Tumor-Syndrome":1,
"Verrucous Carcinoma":1,
"lymph node posterior to right recurrent laryngeal nerve":1,
"model":1,
"BRAFV600E":2,
"Biological marker":1,
"Microarray":1,
"Lymphovascular invasion":1,
"YAP1":1,
"miR-497":1,
"thyroid papillary carcinoma":2,
"Endocrinology":1,
"Transcription":2,
"Clinical features":2,
"Malignant tumors":1,
"Neuromyelitis optica spectrum disorders":1,
"Influencing factors":1,
"Iodine radioisotopes":3,
"Treatment outcome":1,
"cytotoxicity":3,
"differentiation":1,
"immune escape":1,
"natural killer cell":1,
"prostaglandin E2":1,
"endocrine":1,
"follicular adenoma":2,
"follicular carcinoma":2,
"organ system pathology":1,
"pathology competencies":1,
"AP-2α":1,
"notch signaling":1,
"heme oxygenase":1,
"reactive oxygen species":2,
"endocrine disruptors":1,
"flame retardants":1,
"polybrominated diphenyl ethers":1,
"brainstem / cerebellum":1,
"cancer - see oncology":1,
"immunology":1,
"Taiwan":1,
"bladder cancer":1,
"prostate cancer":2,
"vitiligo":1,
"cytopathology":1,
"thyroid Bethesda system":1,
"thyroid FNA":1,
"thyroid indeterminate lesions":1,
"Circular RNA":2,
"miRNA":1,
"nuclear medicine":1,
"XIST":1,
"miR-141":1,
"Borderline tumor":1,
"non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"precursor tumor":1,
"uncertain malignant potential (UMP)":1,
"robotic surgery":1,
"Transoral thyroidectomy":1,
"completion thyroidectomy":1,
"remote-access thyroidectomy":1,
"carcinoma of thyroid":1,
"hot nodule":1,
"CXC chemokine receptor":1,
"squamous cell carcinoma of head and neck":1,
"stromal cell-derived factor-1":1,
"loss of signal":1,
"nerve injury":1,
"staged thyroidectomy":1,
"endocrine malignancy":1,
"systemic inflammation response index (SIRI)":1,
"cancer-specific survival":1,
"propensity score matching":1,
"Bilaterality":1,
"Surgical margin":1,
"whole-exome-sequencing":1,
"CEACAM1":1,
"Cowden syndrome":1,
"MALT lymphoma":1,
"MIB2":1,
"PTEN":1,
"renal carcinoma":1,
"BRAF inhibitors":1,
"medullary thyroid cancer":1,
"Screening":2,
"Carcinoma, hepatocellular":2,
"Cirrhosis":1,
"Hepatitis B virus":1,
"Liver failure":1,
"Sarcomatoid carcinoma of pancreas (SCP)":1,
"spindle cell":1,
"undifferentiated pleomorphic sarcoma of the pancreas (UP-PS)":1,
"BRAF(V600E) mutation":1,
"Fine needle aspiration biopsy (FNAB)":1,
"Papillary thyroid cancer (PTC)":1,
"TMPRSS4":1,
"fine needle aspiration biopsy":1,
"fine needle aspiration cytology":1,
"throidectomy":1,
"autopsy":1,
"neoplastic PD-L1 expression divergence or heterogeneity":1,
"classification and regression trees":1,
"liquid based cytology":1,
"machine learning":1,
"morphology":1,
"thyroid cytopathology":1,
"Cohort study":1,
"Treatment strategy":1,
"metastatic renal cell carcinoma":1,
"orbital mass":1,
"orbital metastasis":1,
"Isatis tinctoria":1,
"Antioxidant activity":1,
"Biological activity":1,
"Phenolic profile":1,
"HNF4-α":1,
"NKX2-1 mutation":1,
"non-TRU type":1,
"FFPE tissue":1,
"BRAF(V600E)":1,
"DNA repair":1,
"laparoscopic":1,
"lasso technique":1,
"pancreatectomy":1,
"perioperative outcomes":1,
"ATA guidelines":1,
"Bethesda system":1,
"15q22 locus":1,
"SMAD3":1,
"downstream targets":1,
"functional variants":1,
"Anterior branch":1,
"Extralaryngeal branching":1,
"Intraoperative neuromonitoring":1,
"Motor function":1,
"Aggressive histology":1,
"Micropapillary thyroid cancer":1,
"Minimal extrathyroidal extension":1,
"Tumor diameter":1,
"Asia":1,
"Follicular variant of papillary thyroid carcinoma":1,
"NIFTP":3,
"Carcinoma, papillary follicular/pathology":1,
"Consensus":1,
"Humans":1,
"Observer variation":1,
"Scoring system":2,
"Thyroid cancer, papillary":1,
"BRAF V600E and RET/PTC":1,
"LIMD2":1,
"Metastases":1,
"Safety":2,
"18F-FDG-PET/CT":1,
"lung cancer":1,
"molecular imaging":1,
"oncology: lung":1,
"National Lung Screening Trial":1,
"NAB2-STAT6":1,
"STAT6":1,
"dedifferentiated solitary fibrous tumor":1,
"malignant solitary fibrous tumor":1,
"clinical pathway":1,
"nurse satisfaction":1,
"PRISM-R2":1,
"Quality of life":1,
"Suffering":1,
"Supportive care need":1,
"intraocular":1,
"thyroid medullary carcinoma":1,
"transscleral":1,
"Bethesda category":1,
"FOXP4":1,
"circMYO9B":1,
"miR-4316":1,
"ERα":1,
"ERβ":1,
"Sorafenib":4,
"VDR":1,
"Vitamin D metabolites":1,
"cDtboc":1,
"Early oral feeding":1,
"Gastrectomy":1,
"Multicenter randomized controlled trial":1,
"Postoperative hospital stay":1,
"SPECT/CT":1,
"parallax error":1,
"parathyroid scintigraphy":1,
"pinhole collimator":1,
"thyroid scintigraphy":1,
"thyroglossal duct cyst":1,
"Thyroid Imaging Reporting and Data System (TIRADS)":1,
"atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS)":1,
"ongoing risk stratification":1,
"thyroid cancer in paediatric age":1,
"Lymphocyte-to-monocyte ratio":2,
"Septic arthritis":1,
"Sternoclavicular joint":1,
"Tracheostomy complications":1,
"ASCL1, achaete-scute homolog like 1":1,
"FFPE, formalin-fixed paraffin-embedded section":1,
"NF1B, nuclear factor 1B":1,
"SCLC, small cell lung cancer":1,
"TTF-1, thyroid transcription factor 1":1,
"neuroendocrine differentiation":1,
"CD10":1,
"adenomatous goitre":1,
"thyroid tumour":1,
"circZFR":1,
"Compartment-oriented neck dissection":1,
"Node recurrence":1,
"Soft tissue infiltrate recurrence":1,
"PPP2R2A":1,
"miR-222":1,
"Epac":1,
"PKA":1,
"PRKAR1A":1,
"Rap1":1,
"AXL":1,
"MTC":1,
"miR-144":1,
"miR-34a":1,
"LRP4":1,
"MMP11":1,
"linc01561":1,
"miR-145-5p":1,
"mixOmics":1,
"Fold change":1,
"MiRNA-221":1,
"MiRNA-222":1,
"mortality":3,
"trend":1,
"CTV = clinical target volume":1,
"IMRT = intensity-modulated radiation therapy":1,
"IORT = intraoperative radiotherapy":1,
"MESCC":1,
"MESCC = metastatic epidural spinal cord compression":1,
"OAR = organ at risk":1,
"PRISM = prognostic index for spinal metastases":1,
"PTV = planning target volume":1,
"RPA = recursive partitioning analysis":1,
"RT = radiation therapy":1,
"SBRT = stereotactic body radiotherapy":1,
"decompressive surgery":1,
"postoperative spine SBRT":1,
"re-irradiation":1,
"Liver cancer":1,
"Liver cancer stem cell":1,
"Probenecid":1,
"Self-renewal":1,
"Tranilast":1,
"Transient receptor potential vanilloid-type 2 channel":1,
"microRNA-608":1,
"polymorphism":1,
"susceptibility":1,
"Diffuse sclerosing variant":1,
"Disease-specific survival":1,
"Tall cell variant":1,
"demography":1,
"reoperation":1,
"Angiogenesis":2,
"HDAC9":1,
"Triple negative breast cancer":1,
"Geriatric":2,
"NSQIP":1,
"Older patients":1,
"Dysthyroid eye disease":1,
"Glucocortoid-resistant":1,
"Graves’ orbitopathy":1,
"Rituximab":1,
"Neuroblastoma":1,
"Paediatric cancer treatment":1,
"Paediatric isolation":1,
"Thyroid cancer treatment":1,
"Thyrotoxicosis":1,
"surveillance":1,
"Preoperative":1,
"Aggressive variants":1,
"Persistent":1,
"Negative":1,
"LNM":1,
"incomplete treatment":1,
"Hypothyroidism":1,
"hemithyroidectomy":1,
"Thy":1,
"China":2,
"Life expectancy":1,
"ER ɑ":1,
"RNF168":1,
"external validation":1,
"metastatic epidural spinal cord compression":1,
"predictive factors":1,
"prospective study":1,
"Follow-up":2,
"Papillary follicular/pathology":1,
"Reclassification":1,
"atrophy":1,
"clinical characteristics":1,
"itching":1,
"vulvar lichen sclerosus":1,
"ARO":1,
"ascorbic acid":1,
"catalase":1,
"juglone":1,
"superoxide dismutase":1,
"Non-small cell lung cancer":1,
"CXCR5 + CD8+ T cells":1,
"Foxp3":1,
"miR-125b":1,
"pancreatic cancer":1,
"zinc transporter ZIP4":1,
"Estrogen":1,
"Nuclear factor erythroid 2-related factor 2 (NRF2)":1,
"Resveratrol":1,
"UDP-Glucuronosyltransferase (UGT)":1,
"Cancer-associated fibroblasts":1,
"Risk factor":2,
"MAL2":1,
"MiR-129":1,
"Tumor growth":1,
"MEG3":1,
"Thyroid carcinoma(131)I radioactivity":1,
"miR-182":1,
"Copy number amplification":1,
"LINC01061":1,
"Cyclin D":1,
"Cyclin E":1,
"G(1)/S transition":1,
"Adverse events":1,
"Hypertension":1,
"Patient Safety":1,
"Protein kinase inhibitors":1,
"Proteinuria":1,
"chyle":1,
"Cancer stem cells":2,
"Sphere formation":1,
"CT scan":1,
"Young population":1,
"Adrenal cortex":1,
"Adrenal medulla":1,
"Adrenal rest tumor":1,
"Ectopia":2,
"Ectopic ACTH syndrome":1,
"DNA damage avoidance":1,
"Human MutT homologue 1":1,
"Prox1-as1":1,
"BRAF inhibitor":1,
"Vemurafenib":1,
"Blindness":1,
"Diplopia":1,
"ICT":1,
"Thrombosis":1,
"Insulin resistance":1,
"Parasitic nodule":1,
"Parathyroid glands":1,
"Parathyromatosis":1,
"Thyroid dysgenesis":1,
"Esophagus":1,
"Gastrointestinal tract":1,
"Heterotopia":1,
"Intestine":1,
"Stomach":1,
"131I":1,
"classifications":1,
"radioiodine refractory":1,
"IMRT":1,
"concurrent chemoradiation therapy":1,
"TIRADS":1,
"imaging":1,
"PI3 kinase pathway":1,
"refractory thyroid cancer":1,
"low- and intermediate-ATA risk":1,
"classic papillary thyroid cancer":1,
"nonexcellent response":1,
"Neoplasm invasiveness":2,
"interprofessional care":1,
"interprofessional team":1,
"phenomenology":1,
"(PubMED CID: 11707110)":1,
"50922675)":1,
"Binimetinib (PubMED CID: 10288191)":1,
"Catalytic spine":1,
"Cobimetanib (PubMED CID: 16222096)":1,
"Dabrafenib: (PubMED CID: 44462760)":1,
"Encorafenib: (PubMED CID":1,
"K/E/D/D":1,
"LY3009120 (PubMED CID: 71721540)":1,
"Lifirafenib: (PubMED CID:89670174)":1,
"PLX7904: (PubMED CID: 901169945)":1,
"Protein kinase inhibitor classification":1,
"Protein kinase structure":1,
"Sorafenib: (PubMED CID: 216239)":1,
"Targeted cancer therapy":1,
"Vemurafenib: (PubMED CID: 42611257)":1,
"neovascularization":1,
"tyrosine kinase receptor inhibitors":1,
"vascular mimicry":1,
"vasculogenesis":1,
"scinderin":1,
"mRNA":1,
"TPC-1":1,
"bleomycin":1,
"polarization":1,
"tumor-associated macrophages":1,
"cisplatin":2,
"octreotide":1,
"side population":1,
"tolerance":1,
"toxicity":1,
"Breast tissue":1,
"Human intervention studies":1,
"Isoflavones":1,
"Observational studies":1,
"Safety evaluation":1,
"Thyroid hormone system":1,
"actin skeleton":1,
"ginsenoside Rg3":1,
"Deiodination":1,
"FT(3)/FT(4)":1,
"Refractory":1,
"Metastatic lymph node ratio":1,
"SDC4":1,
"Wnt/β-catenin signaling pathway":1,
"epithelial mesenchymal transition":1,
"NFκB":1,
"matrix metalloproteinases (MMP)-11":1,
"p65":1,
"Carotid artery pulsation":1,
"Diagnostic performance":1,
"Elasticity contrast index":1,
"Immune checkpoint blockade":1,
"Immune-related adverse events":1,
"Macroadenoma":1,
"FNAB":1,
"cancer biology":1,
"copy number alteration":1,
"human":1,
"human biology":1,
"medicine":1,
"Glycolysis":1,
"HCC":1,
"HIF-1α":1,
"Hypoxia":1,
"Yes-associated protein (YAP)":1,
"bilateral axillo-breast approach":1,
"comparison":1,
"Circ-ITCH":1,
"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"Synovial sarcoma":1,
"Primary tumor score":1,
"depth of tumor invasion":1,
"esophageal squamous cell carcinoma":1,
"tumor length":2,
"bevacizumab":1,
"carboplatin":1,
"pemetrexed":1,
"TERTp mutation":1,
"Immunosuppressant":1,
"Inflammatory bowel diseases":1,
"Radioactive iodine-refractory disease":1,
"subacute thyroiditis":1,
"ACTH = adrenocorticotropic hormone":1,
"FSH = follicle-stimulating hormone":1,
"LH = luteinizing hormone":1,
"PA = pituitary adenoma":1,
"PY = person-year":1,
"TSH = thyroid-stimulating hormone":1,
"VIS = visual impairment scale":1,
"natural history":1,
"nonfunctioning":1,
"observation":1,
"pituitary surgery":1,
"SDHB":1,
"catecholamines":1,
"genetic susceptibility":1,
"paraganglioma":1,
"Parathyroid lesions":1,
"Parathyroidectomy":1,
"Licartin":1,
"Liver transplantation":1,
"Radioimmunotherapy":1,
"Retrograde dissection":1,
"Surgical anatomy":1,
"Surgical technique":1,
"Advanced disease":1,
"Carcinoembryonic antigen":1,
"Tumor marker":1,
"telecytopathology":1,
"net survival":1,
"registries":1,
"survival analysis":1,
"Anlotinib":1,
"NSCLC":2,
"STS":1,
"Tyrosine kinase inhibitor":1,
"VEGFR":1,
"hedgehog proteins":1,
"Inflammatory index":1,
"Genetically engineered mice":1,
"SLC7A5":1,
"locoregional recurrence":1,
"adrenal carcinoma":1,
"neuroendocrine carcinoma":1,
"pituitary carcinoma":1,
"Esophageal cancer":1,
"FDG PET/CT":1,
"Peritumoral halo layer":1,
"Reliability test":1,
"Tumor segmentation":1,
"metabolomics":1,
"FOXO3a":1,
"sirtuin1":1,
"vitamin D":1,
"vitamin D receptor":1,
"OPNa":1,
"matrix calcification":1,
"osteopontin":1,
"psammoma bodies":1,
"Breast neoplasms":1,
"Hypoxia-inducible factor 1":1,
"Smad3 protein":1,
"Transforming growth factor beta1":1,
"lateral lymph node metastasis":1,
"neck mass":1,
"Adequacy and accuracy of FNAC thyroid":1,
"Bethesda system of thyroid cytology reporting":1,
"ultrasound of thyroid":1,
"ultrasound-guided fine-needle aspiration of thyroid tumors":1,
"Atorvastatin":1,
"MDA-MB-231":1,
"ultrastructural changes":1,
"Cancer therapy":1,
"Multikinase inhibitors":1,
"SIRT1":1,
"acetylation":1,
"epigenetic modulation":1,
"secretory organs":1,
"Metazoa":1,
"RAD51":1,
"archaea":1,
"evolution":1,
"network":1,
"cancer epidemiology":1,
"cancer registry data":1,
"health inequalities":1,
"social class":1,
"socioeconomic factors":1,
"Accessory lacrimal gland":1,
"Adenocarcinoma not otherwise specified":1,
"Eyelid":1,
"Gland of Wolfring":1,
"Lacrimal gland":1,
"mammary analog secretory carcinoma":1,
"salivary gland":1,
"Cushing’s syndrome":1,
"Mitotane":1,
"mitotanemia":1,
"ADAM10":1,
"lncRNA SNHG1":1,
"miR-140":1,
"3D Organoids":1,
"3D, 3-dimensional":1,
"5-Fluorouracil":1,
"5FU, 5-fluorouracil":1,
"AV, autophagy vesicle":1,
"CD44":1,
"CD44H, high expression of CD44":1,
"CQ, chloroquine":1,
"DMEM, Dulbecco’s modified Eagle medium":1,
"EMT, epithelial-mesenchymal transition":1,
"ESCC, esophageal squamous cell carcinoma":1,
"FBS, fetal bovine serum":1,
"H&amp":1,
"E, hematoxylin and eosin":1,
"IC50, half maximal inhibitory concentration":1,
"IHC, immunohistochemistry":1,
"LC3, light chain 3":1,
"OPSCC, oropharyngeal squamous cell carcinoma":1,
"PI, propidium iodide":1,
"SCCs, squamous cell carcinomas":1,
"TE11R, 5-fluorouracil–resistant derivative of TE11":1,
"Biphasic synovial sarcoma":1,
"Molecular biology":1,
"mandible":1,
"metastatic tumours":1,
"tibia":1,
"germ cell tumours":1,
"ovary":1,
"strumal carcinoid":1,
"Biomarkers, tumor":1,
"Croatia":1,
"ALK rearrangement":1,
"ROS1 rearrangement":1,
"breast":1,
"thyroid transcription factor-1":1,
"EGFR expression":1,
"EGFR mutation":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2018年第3季度论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
